Quantitative Assessment of Pupillary Light Reflex in Acute Carbon Monoxide

Status Completed

Clinical Trial Summary

Neurological complications after acute carbon monoxide (CO) poisoning can range from transient headache or dizziness to cognitive dysfunction, seizure, permanent anoxic brain damages or death. A recent study reported that a lack of standard pupillary light reflex (sPLR), assessed using a pen light, was a predictor of 30-day neurological sequelae in patients with CO poisoning. Given that the basic sPLR has a poor inter-rater reliability, more objective and quantitative methods are required in the assessment of PLR. An automated pupillometer has been used in the intensive care unit to quantitatively assess the PLR. Therefore, we hypothesized that quantitative assessment of PLR might be associated with neurocognitive sequelae after acute CO poisoning. The purpose of this study was to assess the value of quantitative pupillary reactivity (NPi and qPLR) in comparison to that of sPLR in predicting neurocognitive outcome at 1 month after acute CO poisoning.

Clinical Trial Description

Neurological complications after acute carbon monoxide (CO) poisoning can range from transient headache or dizziness to cognitive dysfunction, seizure, permanent anoxic brain damages or death. Although hyperbaric oxygen therapy (HBO2) has been tried to minimize the neurological complications, a significant percentage of patients still suffer from neurocognitive sequelae after acute CO poisoning. A recent study reported that a lack of standard pupillary light reflex (sPLR), assessed using a pen light, was a predictor of 30-day neurological sequelae in patients with CO poisoning. Given that the basic sPLR has a poor inter-rater reliability, more objective and quantitative methods are required in the assessment of PLR. An automated pupillometer has been used in the intensive care unit to quantitatively assess the PLR. Quantitative PLR (qPLR), which is expressed as the percentage pupillary constriction in response to a calibrated light stimulus, was better in predicting neurological outcome after cardiac arrest (CA) compared to standard light reflex. In addition, the Neurological Pupil index (NPi) has been validated as a tool for assessing prognosis after CA because it is not influenced by medications (especially opioids and neuromuscular blocking agents) or small pupil size. Therefore, the investigators hypothesized that quantitative assessment of PLR might be associated with neurocognitive sequelae after acute CO poisoning. The purpose of this study was to assess the value of quantitative pupillary reactivity (NPi and qPLR) in comparison to that of sPLR in predicting neurocognitive outcome at 1 month after acute CO poisoning. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05110820
Study type	Observational
Source	Wonju Severance Christian Hospital
Contact
Status	Completed
Phase
Start date	August 1, 2019
Completion date	January 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03669848` - Is Transcutaneous Carbon Monoxide Saturation of E-cigarette Users Comparable to That of Smokers?
Completed	`NCT04656912` - Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning
Recruiting	`NCT04975867` - Adjunct Targeted Temperature Management in Acute Severe Carbon Monoxide Poisoning	N/A
Terminated	`NCT01099995` - Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning	Phase 3
Terminated	`NCT01100515` - Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning	Phase 3
Terminated	`NCT03017742` - Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department
Terminated	`NCT01059708` - Outcome Following Carbon Monoxide Poisoning in Children	N/A
Recruiting	`NCT05591300` - Microparticles Blood Level in Acute Carbon Monoxide Poisoning
Not yet recruiting	`NCT04475263` - Cognitive and Blood Biomarker Assessment After CO Exposure
Completed	`NCT03926494` - Carbon Monoxide-induced Coma: Prognostic Factors
Recruiting	`NCT02375126` - Normal Quantitative EEG (qEEG) Dataset
Completed	`NCT03342209` - Utility of High Flow Nasal Cannula in CO Toxicity	N/A
Completed	`NCT00465855` - One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning	Phase 4
Recruiting	`NCT04490317` - CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
Withdrawn	`NCT04118491` - Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy	N/A
Unknown status	`NCT00841165` - Carbon Monoxide Monitoring and Emergency Treatment	N/A
Withdrawn	`NCT00280579` - Cyanide Poisoning in Fire Victims	N/A
Enrolling by invitation	`NCT02483650` - Hyperbaric Oxygen Therapy Registry
Completed	`NCT05088005` - Prognostic Biomarkers in CO Poisoning
Completed	`NCT03030833` - Dysfunctional Hemoglobin Pulse Oximetry	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Quantitative Assessment of Pupillary Light Reflex in Acute Carbon Monoxide Poisoning

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms